Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,658,212
+$1,522,913 QoQ
Shares Held
443,775
+127.9% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MONIMUS CAPITAL MANAGEMENT, LP holds $16,649,678 across 10 Biotechnology names. ARDX ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRTA |
Prothena Corp Public Ltd Co
|
485,617 | $4,720,197 | |
| 2 | ARDX |
Ardelyx, Inc.
This page
|
443,775 | $2,658,212 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
67,841 | $2,207,546 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
19,114 | $1,858,836 | |
| 5 | ASMB |
Assembly Biosciences, Inc.
|
48,390 | $1,342,822 | |
| 6 | PEPG |
PepGen Inc.
|
598,663 | $1,059,633 | |
| 7 | QTTB |
Q32 Bio Inc.
|
134,310 | $862,270 | |
| 8 | TECX |
Tectonic Therapeutic, Inc.
|
26,753 | $826,935 |
All Filings in ARDX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,658,212 | 443,775 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,135,299 | 194,734 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,114,733 | 202,311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $793,059 | 202,311 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $791,624 | 161,227 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||